China Contract Research Organization Market value exceeded USD 1.3 billion in 2017 and is set to register significant growth from 2018 to 2024 supported by fast approval procedures.

Workshop focused on Rosa's Model Qualification Method to be held August 19th, Toronto, Canada.

Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced the appointment of Mike Reed as Vice President.

Diabetes PhysioPD model used to predict long-term clinical outcomes and select doses using only summary pharmacokinetic data from a competitor's short-term Phase I clinical trial

In collaboration with its clients, Lithera, MediciNova, Pfizer, Vitalea, Rosa & Co will present six posters at the 2011 American College on Pharmacometrics in San Diego, CA on April 4, 2011.

Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced the appointment of Sharan A. Pagano, Vice President, Scientific Alliances.

Company Leasing New Office Space, Increasing Workforce Due to Growing Client Portfolio

In collaboration with Vitalea, Inc., Rosa will present a poster at the 2011 American Society for Clinical Pharmacology and Therapeutics in Dallas, TX entitled "Compartmental Analysis of Urosodiol PK in Neonates using AMS" at 8:00 am on March 4, 2011.